Literature DB >> 15278624

Hypoxic ventilatory response in cats lightly anesthetized with ketamine: effects of halothane and sevoflurane in low concentrations.

C Tamura1, M Doi, K Ikeda.   

Abstract

The effect of low concentration sevoflurane and halothane on the ventilatory response to isocapnic hypoxia was studied in sixteen cats. The cats were divided into two groups, sevoflurane group and halothane group, of eight subjects each. As parameters of the hypoxic ventilatory response, A value [the slope of the hyperbolic curve, V(E) = V(0) + A/(Pa(O)(2)-32)] and ratio of V(50) (the minute volume obtained from the hyperbolic equation when Pa(O)(2) = 50 mmHg) to V(0) were studied. These two parameters were examined at three states, sedative state with ketamine as the control, ketamine plus 0.1 MAC inhalation anesthetic, and ketamine plus 0.5 MAC inhalation anesthetic. In the sevoflurane group, the A values were 4789 +/- 1518, 2187 +/- 1214, 1730 +/- 880 (mean +/- SE. ml.min(-1).mmHg) at the control state, 0.1 MAC and 0.5 MAC, respectively. In the halothane group, the A values were 6411 +/- 2368, 2529 +/- 842 and 2372 +/- 545, respectively. The ratios of V(50) to V(0) were 1.32 +/- 0.09, 1.22 +/- 0.09, 1.25 +/- 0.08 in the sevoflurane group, 1.47 +/- 0.18, 1.32 +/- 0.11, 1.54 +/- 0.18 in the halothane group, respectively. The A value at 0.1 MAC of the halothane group was less than the control value significantly. This proved that even low concentration halothane depressed the hypoxic ventilatory responses. The depression of hypoxic ventilatory response could cause postanesthetic hypoventilation. On the other hand, we could not find significant depression on the hypoxic ventilatory response in the sevoflurane group, but we should notice that variances of the hypoxic ventilatory response were large.

Entities:  

Year:  1991        PMID: 15278624     DOI: 10.1007/s0054010050233

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  11 in total

1.  The relation between alveolar oxygen pressure and the respiratory response to carbon dioxide in man.

Authors:  B B LLOYD; M G JUKES; D J CUNNINGHAM
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1958-04

2.  Effects of halothane on canine respiratory responses to hypoxia with and without hypercarbia.

Authors:  R B Weiskopf; L W Raymond; J W Severinghaus
Journal:  Anesthesiology       Date:  1974-10       Impact factor: 7.892

3.  Comparison of three methods for quantitating respiratory response to hypoxia in man.

Authors:  R Kronenberg; F N Hamilton; R Gabel; R Hickey; D J Read; J Severinghaus
Journal:  Respir Physiol       Date:  1972-09

4.  [Effects of the peripheral chemoreceptor denervation and increasing depths of halothane anesthesia on hypoxic respiratory depression].

Authors:  T Kohchi; T Nishino; Y Honda; T Yonezawa; T Mizuguchi
Journal:  Masui       Date:  1986-11

Review 5.  [Low responders and hypoxic depression in hypoxic ventilatory responses].

Authors:  M Nishimura; Y Kawakami
Journal:  Kokyu To Junkan       Date:  1984-04

6.  Non-invasive measurement of ventilation during exercise using a respiratory inductive plethysmograph. I.

Authors:  J D Sackner; A J Nixon; B Davis; N Atkins; M A Sackner
Journal:  Am Rev Respir Dis       Date:  1980-12

7.  Hypoxic ventilatory drive in dogs during thiopental, ketamine, or pentobarbital anesthesia.

Authors:  C A Hirshman; R E McCullough; P J Cohen; J V Weil
Journal:  Anesthesiology       Date:  1975-12       Impact factor: 7.892

8.  Depression of ventilation hypoxia in man.

Authors:  R B Weiskoff; R A Gabel
Journal:  J Appl Physiol       Date:  1975-12       Impact factor: 3.531

9.  Hypoxic ventilatory drive in normal man.

Authors:  J V Weil; E Byrne-Quinn; I E Sodal; W O Friesen; B Underhill; G F Filley; R F Grover
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

10.  Ventilatory responses to hypoxia and hypercapnia during halothane sedation and anesthesia in man.

Authors:  R L Knill; A W Gelb
Journal:  Anesthesiology       Date:  1978-10       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.